monarchE Trial Efficacy and Safety Results by Age in High-risk Early Breast Cancer Breast 3 Mins Read17 Erika Hamilton, MD, a preeminent expert from the Sarah Cannon Research Institute, has recently conducted a study evaluating the efficacy…
T-DXd HER2-Positive Breast Cancer: DESTINY-Breast03 Breast 12 Mins Read1 T-DXd HER2-Positive Breast Cancer: DESTINY-Breast03 DESTINY-Breast03 Phase 3 clinical trial Study Design for HER2-Positive Breast Cancer This was a safety…
